Interestingly, CXCL12 neutralization by NOX-A12 chemosensitizes CLL, MM, and CML cells resulting in their reduced survival in vitro or tumor burden in vivo (101, 128, 129). The gene discussed is CXCL12; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.